• Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • In recent years, researchers at @theNCI found the death rate among uterine cancer patients has increased significantly for all women, but it disproportionately affects Black women, who have twice the death rate, overall, compared to other groups #utca: https://t.co/KhbuEtvgsU https://t.co/XA7uo2h0Qm

  • Mashup Score: 0
    The Cancer News Daily - 2 year(s) ago

    The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD

    Tweet Tweets with this article
    • The latest The Cancer News Daily! https://t.co/QueLb9quvi Thanks to @HopkinsMedicine @FaltasLab @Nature #utca

  • Mashup Score: 1
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • In recent years, researchers at @theNCI found the death rate among uterine cancer patients has increased significantly for all women, but it disproportionately affects Black women, who have twice the death rate, overall, compared to other groups #utca: https://t.co/W1eumNcrpA https://t.co/kIx5rxWzi5

  • Mashup Score: 0

    A 73-gene proliferative transcriptomic signature was found to better predict overall survival outcomes and potentially be used to personalize treatment in patients with uterine serous carcinoma.

    Tweet Tweets with this article
    • A 73-gene proliferative transcriptomic signature was found to better predict overall survival outcomes and potentially be used to personalize treatment in patients with uterine serous carcinoma, according to results of a retrospective study. #utca #gynca https://t.co/hh1GUbh7D8

  • Mashup Score: 4

    Skip to contentAboutEditorial BoardExpert IndexCookie PolicyTerms of UsePrivacy PolicyEditorial policySign upContactNewsletters Visit Home (current) Diseases Genitourinary Lung Head and Neck Breast Gynecological Skin View all Diseases Topics Treatment Early Diagnosis Nursing Pharmacy Supportive Care Policy View all Topics Conferences ESMO Breast 2020 GU…

    Tweet Tweets with this article
    • Coming up next on the #ASCO20 program: highlights session in #GynecologicCancers. @VJOncology spoke to @DrMatulonis of @DanaFarber on the KEYNOTE-100 trial and #adavosertib You can find the interview on 👉https://t.co/2lSF5ftQz8👈 @ASCO #GYNcsm #GynOnc #utca #ovca #OncoAlert https://t.co/h9BnDV815D